Response and seroconversion rates among HBeAg-positive chronic HBV Egyptian patients treated with peginterferon alpha 2a (Pegasys), a single-centre experience

Citation:
Maklad, S., G. Esmat, W. Doss, A. Abou-Zeid, and S. S. El-Din, "Response and seroconversion rates among HBeAg-positive chronic HBV Egyptian patients treated with peginterferon alpha 2a (Pegasys), a single-centre experience", Arab Journal of Gastroenterology, vol. 14, no. 2: Elsevier, pp. 73–77, 2013.

Abstract:

n/a

Notes:

n/a